Dosing, Administration, and Best Practices Recommended Dosing Protocols Dosing for BPC-157 TB-500 nasal spray varies based on individual goals, body weight, and the specific concentration of the formulation: Typical BPC-157 Dosing Maintenance: 250-500 mcg per day Active recovery: 500-750 mcg per day Acute injury: 750-1000 mcg per day (divided doses) Typical TB-500 Dosing Maintenance: 2-2.5 mg twice weekly Loading phase: 5-10 mg weekly (first 4-6 weeks) Maintenance phase: 2-5 mg weekly thereafter Combined Nasal Spray Formulations often provide both peptides in ratios designed for convenient once or twice-daily administration
NAMPT-induced genes associated with effectors of stemness pathways, which increased tumorigenicity and regulated the CSC phenotype
Cell 142 , 203217 (2010)
Large, well-designed Phase II/III RCTs with distinct primary goals, uniform diagnostic criteria, and active comparators are needed
MOMP results in the release of mitochondrial intermembrane space proteins, most notably cytochrome c, into the cytosol
10.1371/journal.pone.0123454 89 SucicM.LueticK.JandricI.DrmicD.SeverA
